Tax or exercise withholding
Paul Anthony Williams
SVP, Products Business
Common Stock
- Value context
- $5.55K
- Reported price
- $8.00 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Emergent BioSolutions Inc.
Last 30 daysNo qualifying insider buying. Sales: $145.79K by 2 insiders.
Showing the first 6 of 29 trades on this page.
SVP, Products Business
Common Stock
EVP, Chief Financial Officer
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
EVP, Quality & Ethics, and CPL
Common Stock
SVP, Bioservices
Common Stock
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chairman
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chairman
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
SVP, Products Business
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
SVP, R&D, CMO
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP, Quality & Ethics, and CPL
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP, Chief Financial Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
SVP, General Counsel, Corp Sec
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
SVP, Bioservices
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President and CEO
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| SVP, Products Business | Common StockExercise-price or tax withholding | 694$8.00 / share | $5.55K | Jun 8Filed Jun 10 · 2d later | SEC filing |
| EVP, Chief Financial Officer | Common StockExercise-price or tax withholding | 3,964$8.00 / share | $31.71K | Jun 8Filed Jun 10 · 2d later | SEC filing |
| EVP, Quality & Ethics, and CPL | Common StockExercise-price or tax withholding | 2,018$8.00 / share | $16.14K | Jun 8Filed Jun 10 · 2d later | SEC filing |
| SVP, Bioservices | Common StockExercise-price or tax withholding | 1,741$8.00 / share | $13.93K | Jun 8Filed Jun 10 · 2d later | SEC filing |
| Director | Common StockGrant or award10b5-1 | 25,344Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award10b5-1 | Derivative units11,296Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockGrant or award10b5-1 | 25,344Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award10b5-1 | Derivative units11,296Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockGrant or award10b5-1 | 25,344Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Stock Options (Right to Buy)Grant or award10b5-1 | Derivative units11,296Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockGrant or award | 25,344Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units11,296Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockGrant or award | 25,344Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units11,296Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockGrant or award | 25,344Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units11,296Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockGrant or award10b5-1 | 25,344Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award10b5-1 | Derivative units11,296Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockGrant or award | 25,344Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units11,296Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Chairman | Common StockGrant or award | 25,344Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Chairman | Stock Option (Right to Buy)Grant or award | Derivative units11,296Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| SVP, Products Business | Common StockGrant or award | 100,111Award · no purchase price | Non-cash award | Apr 29Filed May 1 · 2d later | SEC filing |
| SVP, R&D, CMO | Common StockGrant or award | 100,111Award · no purchase price | Non-cash award | Apr 29Filed May 1 · 2d later | SEC filing |
| EVP, Quality & Ethics, and CPL | Common StockGrant or award | 100,111Award · no purchase price | Non-cash award | Apr 29Filed May 1 · 2d later | SEC filing |
| EVP, Chief Financial Officer | Common StockGrant or award | 162,680Award · no purchase price | Non-cash award | Apr 29Filed May 1 · 2d later | SEC filing |
| SVP, General Counsel, Corp Sec | Common StockGrant or award | 104,282Award · no purchase price | Non-cash award | Apr 29Filed May 1 · 2d later | SEC filing |
| SVP, Bioservices | Common StockGrant or award | 100,111Award · no purchase price | Non-cash award | Apr 29Filed May 1 · 2d later | SEC filing |
| President and CEO | Common StockGrant or award | 187,708Award · no purchase price | Non-cash award | Apr 29Filed May 1 · 2d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.